Comparison of two drugs levosimendan and milrinone for better outcome of coronary artery bypass grafting surgery
Phase 4
- Conditions
- Health Condition 1: I251- Atherosclerotic heart disease of native coronary arteryHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2022/02/040134
- Lead Sponsor
- IPGMER and SSKM Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Triple vessel disease fulfilling the criteria for OPCAB
Ejection fraction (EF) 35-55%
Exclusion Criteria
I. Patientâ??s refusal
ii. Known allergy to any of the drug
iii. NYHA Grade 4
iv. Presence of haemodynamically significant arrhythmia
v. Left main coronary artery involvement
vi. Presence of hepatic / renal disease
vii. Presence of neurological disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method